Find Clinical Trial

Clinical Investigation to Determine the Accuracy and Benefit of Cardioskin™ in Patients With Known Atrial Fibrillation

← Back
Study Phase

Phase 3

Therapeutic Area

Cardiovascular Diseases

Active substance/
Medical device


SponsorInstitut de Recherches Internationales Servier
Active Substance CodeCardioskin™
Protocol CodeCL3-13001-002
NCT CodeNCT03964025

Documents and links

Results are not yet available.

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.

© 2017 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
More information

Report a side-effect with a drug.